sasanlimab
Showing 1 - 8 of 8
Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute
Not yet recruiting
- Advanced Clear Cell Renal Carcinoma (Ccrcc)
- Papillary Renal Cell Carcinoma (Prcc)
- Sasanlimab
- Palbocicilib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)
Recruiting
- Advanced Solid Tumors
- +5 more
- PF-07265028
- Sasanlimab
-
Scottsdale, Arizona
- +7 more
Jan 23, 2023
Urothelial Carcinoma Bladder Trial in Houston (drug, radiation, procedure)
Recruiting
- Urothelial Carcinoma Bladder
- Sasanlimab
- +2 more
-
Houston, TexasHouston Methodist Hospital
Feb 15, 2022
NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Sasanlimab Prefilled syringe
- +5 more
-
Duarte, California
- +96 more
Jan 18, 2023
NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)
Recruiting
- Non-small Cell Lung Cancer
- +11 more
- SEA-TGT
- sasanlimab
-
Birmingham, Alabama
- +32 more
Jan 4, 2023